Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Spain

Research and Innovation Action · Running

ENKORE Propelling the shift toward the future of circular, safe and sustainable packaging and single use device ecoDesigned solutions through healthcare environments

Coordinator
Universidad Politecnica De Madrid, Spain
Runs
1 January 2025 to 31 December 2028
Status
Running
EU funding
€7.7m
Total cost
€14.5m
Partners
52 organisations in 15 countries
Type
Research and Innovation Action
Grant agreement
101166707

What the project is doing

In the project's own words, from its summary on CORDIS.

The healthcare sector is hindered by several barriers that hamper the application of circular economy principles (e.g. the safety restrictions of the domain limit the use of recycled materials due to the need of materials biocompatibility, and safety in products to be used in the human body). Led by a multidisciplinary consortium of 39 partners (plus 13 industry affiliates) from 15 EU countries plus UK and USA, ENKORE aim to tackle challenges and develop an ecoDesign framework that supports the development of safe and environmental compliant devices eco-responsible packaging, which minimize the environmental impact, reduce the carbon footprint, and maximize the use and preservation of resources.

The main goal is to connect the design of the medical devices packages with the end-of-life stage, thus the technologies that support circularity are taken into account at the medical device conception stage. ENKORE framework will be validated in 5 Reference Use Cases (RUCs), led by 5 different health regions that bring HPCs and policy maker, 3 large EU hospitals and the reference network for European Regional and Local Health Authorities (EUREGHA).

The project developments and RUCs are supported by several associations and NGOs, a packaging manufacturer and a group of SMEs and researchers, specialists in circularity, LCA, social sciences, environment, circularity, and materials. The validation of the framework shall provide evidence to work with policymakers, creating new or revised standards and create tangible/quantitative evidence. Policy making and regulatory engagement will be strongly performed.

The methods and tools comprise Environmental and Social Life Cycle Assessment (ELCA/SLCA), Circularity Calculator (CC) and Digital Product Passport (DPP) approaches, which could be adapted during the second stage of the proposal.

Topics

Who is involved

OrganisationCityCountryRole
Universidad Politecnica De MadridMadridSpainCoordinator
Naucnoistrazivacki Institut Verlab Za Biomedicinski Inzinjering Medicinske Uredaje I Vjestacku InteligencijuSarajevoBosnia and HerzegovinaParticipant
Baxter R and D EuropeLessinesBelgiumParticipant
European Regional and Local Health Authorities ASBLEtterbeekBelgiumParticipant
Forum Des Patients EuropeensBruxelles / BrusselBelgiumParticipant
Takeda Pharmaceuticals International AGGlattparkSwitzerlandParticipant
Udg AllianceLausanneSwitzerlandAssociatedpartner
World Resources Forum AssociationWinterthurSwitzerlandAssociatedpartner
Boehringer Ingelheim InternationalgmbhIngelheimGermanyParticipant
Boehringer Ingelheim Pharma GmbH &co KgIngelheimGermanyAssociatedpartner
Charite - Universitaetsmedizin BerlinBerlinGermanyParticipant
Fresenius Medical Care Deutschland GmbHBad HomburgGermanyParticipant
Johnson & Johnson Medical GmbHNorderstedtGermanyParticipant
Lilly Deutschland GmbHBad HomburgGermanyAssociatedpartner
Pfizer Manufacturing Deutschland GmbH mit Sitz IllertissenIllertissenGermanyAssociatedpartner
Eli Lilly Danmark A/SHerlevDenmarkAssociatedpartner
Novo Nordisk A/sBagsvaerdDenmarkParticipant
Enosi Asthenon ElladasAthinaGreeceParticipant
Idryma Technologias Kai ErevnasIrakleioGreeceParticipant
Institoyto Bioiatrikis TexnologiasPatrasGreeceParticipant
Tech Hive Labs Astiki Mi Kerdoskopiki EtaireiaChalandriGreeceParticipant
Active Ageing AssociationPaternaSpainParticipant
Consorcio Mar Parc De Salut De BarcelonaBarcelonaSpainParticipant
Fundacion Universidad Francisco De VitoriaPozuelo De AlarconSpainParticipant
Happy Mondays Communication SLMadridSpainParticipant
Medtronic Iberica SAMadridSpainParticipant
Predictby Research and Consulting S.l.BarcelonaSpainParticipant
Servicio Madrileno De SaludMadridSpainParticipant
Sofradim Production SasuTrevouxFranceThird party
Sterimed HoldingBoulogne BillancourtFranceParticipant
Pfizer Ireland PharmaceuticalsCorkIrelandAssociatedpartner
Agenzia Regionale per La Salute Ed Il SocialeBariItalyParticipant
Fondazione Policlinico Universitario Campus Bio MedicoRomaItalyParticipant
Multimed Engineers SRLParmaItalyParticipant
Osai Automation System SpA Societa' BenefitTorinoItalyParticipant
Pfizer Italia s.r.l.LatinaItalyAssociatedpartner
Universita Campus Bio Medico Di RomaRomaItalyParticipant
Dupont De Nemours (luxembourg) SARLLuxembourgLuxembourgParticipant
International Solid Waste AssociationRotterdamNetherlandsParticipant
Samenwerkende Topklinische OpleidingsziekenhuizenUtrechtNetherlandsParticipant
Universiteit LeidenLeidenNetherlandsParticipant
Politechnika PoznanskaPoznanPolandParticipant
Uniwersytet Medyczny W LodziLodzPolandParticipant
DePuy International LimitedLeedsUnited KingdomAssociatedpartner
Eli Lilly and Company LtdBasingstokeUnited KingdomAssociatedpartner
Pfizer LimitedSandwichUnited KingdomAssociatedpartner
Pfizer R&D UK LimitedSandwichUnited KingdomAssociatedpartner
Technovative Solutions LtdManchesterUnited KingdomAssociatedpartner
Boehringer Ingelheim Pharmaceuticals, Inc.RidgefieldUnited StatesAssociatedpartner
Eli Lilly and CompanyIndianapolisUnited StatesParticipant
Johnson & Johnson Services, Inc.New BrunswickUnited StatesAssociatedpartner
Pfizer IncNew York CityUnited StatesParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI